Skip to content

The effect of Sodium Pentaborate In Anal fissure

Evaluation of the effect of Sodium Pentaborate Topical Ointment on Anal fissure symptoms and treatment

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20190701044062N7
Enrollment
140
Registered
2021-07-14
Start date
2020-09-05
Completion date
Unknown
Last updated
2021-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anal fissure. Anal fissure, unspecified

Interventions

Intervention 1: Intervention group: Topical ointment of 3% sodium pentaborate, which is made under GLP and GMP conditions at Yeditpe University in Turkey and is applied to the wound for 14 days (2 wee

Sponsors

Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Chronic anal fissure that is detected in the perineal area by direct observation or rigid anoscopy or flexible colonoscopy.

Exclusion criteria

Exclusion criteria: Existence of any perineal complications including dermatitis, wart, condyloma, hemorrhoids, fistula, anal abscess 2. Proven Crohn's disease 3. Existence of lateral fissure 4. Patients with sodium pentaborate allergy 5. Pregnancy or breastfeeding 6. Patients with a history of serious cardiovascular, hepatic, renal and blood diseases 7. Taking any topical anal medication during the last 7 days 8. Prohibition of topical use of sodium pentaborate being under the age of 18

Design outcomes

Primary

MeasureTime frame
Anal itching. Timepoint: At the beginning of the study (before the intervention) and 14 days (2 weeks) after starting the ointment. Method of measurement: Ask the patient.;Anal bleeding. Timepoint: At the beginning of the study (before the intervention) and 14 days (2 weeks) after starting the ointment. Method of measurement: Ask the patient, inspection of anus and digital rectal examination.;Anal pain at rest. Timepoint: At the beginning of the study (before the intervention) and 14 days (2 weeks) after starting the ointment. Method of measurement: Ask the patient.;Anal pain during defecation. Timepoint: At the beginning of the study (before the intervention) and 14 days (2 weeks) after starting the ointment. Method of measurement: Ask the patient.;Bleeding from the fissure during the examination. Timepoint: At the beginning of the study (before the intervention) and 14 days (2 weeks) after starting the ointment. Method of measurement: Inspection of anus and digital rectal examination.;Pain at the Fissure site during the examination. Timepoint: At the beginning of the study (before the intervention) and 14 days (2 weeks) after starting the ointment. Method of measurement: Ask the patient, inspection of anus and digital rectal examination.

Secondary

MeasureTime frame
Anal pain during defecation. Timepoint: At the beginning of the study (before the intervention) and 14 days (2 weeks) after starting the ointment. Method of measurement: Ask the patient.;Feeling of a mass around the anus. Timepoint: At the beginning of the study (before the intervention) and 14 days (2 weeks) after starting the ointment. Method of measurement: Ask the patient.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactManouchehr Khoshbaten

Tabriz University of Medical Sciences

mkhoshbaten@yahoo.com+98 41 3335 9680

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026